Forbes August 20, 2018
For a sector where the outcomes matter so much more than the inputs, the diagnosis on the U.S. healthcare industry is not great. The prognosis is not much better, especially as tectonic shifts are afoot in the U.S., which ranks last in The Commonwealth Fund’s benchmarking of advanced economy health systems. By this measure, the market making moves by Amazon’s triumvirate with JPMorgan Chase and Berkshire Hathaway should be watched very carefully as a portent for how technology (courtesy of Amazon), scale (courtesy of their combined 1 million employees), and financial and actuarial acumen (courtesy of JPMorgan and Berkshire Hathaway’s financial and insurance prowess), shape the industry. If the Amazon triumvirate is a very large beta test for how corporations...